Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidating Statements of Cash Flows (Detail)

v2.4.0.8
Condensed Consolidating Statements of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
May 31, 2014
May 31, 2013
Operating Activities    
Net cash provided by operating activities $ 73,186 $ 116,270
Investing Activities    
Capital expenditures (33,839) (18,895)
Proceeds from sale of property, plant and equipment 44,036 1,317
Proceeds from sale of businesses, net of transaction costs 252,773 4,854
Intercompany investment 0  
Business acquisitions, net of cash acquired (30,500) (83)
Net cash provided by (used in) investing activities 232,470 (12,807)
Financing Activities    
Net repayments on revolver (125,000) 0
Principal repayments on term loan 0 (5,000)
Intercompany loan activity 0 0
Intercompany capital contribution 0  
Purchase of treasury shares (183,152) (13,670)
Payment of contingent acquisition consideration (1,585) (3,552)
Stock option exercises and related tax benefits 29,849 18,705
Cash dividend (2,919) (2,911)
Net cash used in financing activities (282,807) (6,428)
Effect of exchange rate changes on cash 2,790 (3,801)
Net increase (decrease) in cash and cash equivalents 25,639 93,234
Cash and cash equivalents – beginning of period 103,986 68,184
Cash and cash equivalents – end of period 129,625 161,418
Parent
    
Operating Activities    
Net cash provided by operating activities 33,121 61,900
Investing Activities    
Capital expenditures (3,823) (1,387)
Proceeds from sale of property, plant and equipment 52 554
Proceeds from sale of businesses, net of transaction costs (4,586) 0
Intercompany investment 0  
Business acquisitions, net of cash acquired (30,500) 0
Net cash provided by (used in) investing activities (38,857) (833)
Financing Activities    
Net repayments on revolver (125,000)  
Principal repayments on term loan   (5,000)
Intercompany loan activity 313,748 (42,904)
Intercompany capital contribution 0  
Purchase of treasury shares (183,152) (13,670)
Payment of contingent acquisition consideration 0 (1,350)
Stock option exercises and related tax benefits 29,849 18,705
Cash dividend (2,919) (2,911)
Net cash used in financing activities 32,526 (47,130)
Effect of exchange rate changes on cash 0 0
Net increase (decrease) in cash and cash equivalents 26,790 13,937
Cash and cash equivalents – beginning of period 16,122 12,401
Cash and cash equivalents – end of period 42,912 26,338
Guarantors
    
Operating Activities    
Net cash provided by operating activities 10,376 28,192
Investing Activities    
Capital expenditures (3,558) (3,461)
Proceeds from sale of property, plant and equipment 484 75
Proceeds from sale of businesses, net of transaction costs 214,268 0
Intercompany investment (99,963)  
Business acquisitions, net of cash acquired 0 0
Net cash provided by (used in) investing activities 111,231 (3,386)
Financing Activities    
Net repayments on revolver 0  
Principal repayments on term loan   0
Intercompany loan activity (118,216) (24,897)
Intercompany capital contribution 0  
Purchase of treasury shares 0 0
Payment of contingent acquisition consideration 0 0
Stock option exercises and related tax benefits 0 0
Cash dividend 0 0
Net cash used in financing activities (118,216) (24,897)
Effect of exchange rate changes on cash 0 0
Net increase (decrease) in cash and cash equivalents 3,391 (91)
Cash and cash equivalents – beginning of period 0 91
Cash and cash equivalents – end of period 3,391 0
Non-Guarantors
    
Operating Activities    
Net cash provided by operating activities 44,405 26,178
Investing Activities    
Capital expenditures (26,458) (14,047)
Proceeds from sale of property, plant and equipment 43,500 688
Proceeds from sale of businesses, net of transaction costs 43,091 4,854
Intercompany investment 0  
Business acquisitions, net of cash acquired 0 (83)
Net cash provided by (used in) investing activities 60,133 (8,588)
Financing Activities    
Net repayments on revolver 0  
Principal repayments on term loan   0
Intercompany loan activity (195,532) 67,801
Intercompany capital contribution 99,963  
Purchase of treasury shares 0 0
Payment of contingent acquisition consideration (1,585) (2,202)
Stock option exercises and related tax benefits 0 0
Cash dividend (14,716) 0
Net cash used in financing activities (111,870) 65,599
Effect of exchange rate changes on cash 2,790 (3,801)
Net increase (decrease) in cash and cash equivalents (4,542) 79,388
Cash and cash equivalents – beginning of period 87,864 55,692
Cash and cash equivalents – end of period 83,322 135,080
Eliminations
    
Operating Activities    
Net cash provided by operating activities (14,716) 0
Investing Activities    
Capital expenditures 0 0
Proceeds from sale of property, plant and equipment 0 0
Proceeds from sale of businesses, net of transaction costs 0 0
Intercompany investment 99,963  
Business acquisitions, net of cash acquired 0 0
Net cash provided by (used in) investing activities 99,963 0
Financing Activities    
Net repayments on revolver 0  
Principal repayments on term loan   0
Intercompany loan activity 0 0
Intercompany capital contribution (99,963)  
Purchase of treasury shares 0 0
Payment of contingent acquisition consideration 0 0
Stock option exercises and related tax benefits 0 0
Cash dividend 14,716 0
Net cash used in financing activities (85,247) 0
Effect of exchange rate changes on cash 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents – beginning of period 0 0
Cash and cash equivalents – end of period $ 0 $ 0